(Press-News.org) Multisystemic smooth muscle dysfunction syndrome (MSMDS) is a rare condition associated with stroke, aortic dissection (tearing) and death in childhood. Currently, there is no effective treatment or cure for MSMDS. A single error in the genetic code of the ACTA2 gene, which encodes the smooth muscle actin protein, is the most common cause of MSMDS. To directly target this mutation, researchers from Mass General Brigham engineered a bespoke CRISPR-Cas9 gene-editing enzyme to develop a potential therapy for MSMDS, which substantially prolonged survival and reduced vascular disease and neurodegeneration in mouse models of MSMDS. Findings are published in Nature Biomedical Engineering.
“The story of this research truly began at the bedside,” said Patricia Musolino, MD, PhD, of the Department of Neurology at Massachusetts General Hospital (MGH), a founding member of the Mass General Brigham healthcare system. “An infant in critical condition first brought together our team, which includes experts on the clinical, genetic, biological and therapeutic aspects of this disease. Now, we have a clear roadmap toward bringing an experimental drug back to the bedside.”
The therapy developed by the researchers relies on a genome editing tool called a base editor, which is comprised of a CRISPR-Cas9 protein fused to DNA modifying enzyme. The Cas9 component is programmed by a guide RNA that helps direct the base editor to the proper site in the genome to make a precise DNA edit. The researchers realized that while a base-editor with a conventional Cas9 protein effectively corrected the ACTA2 mutation causing MSMDS, it also changed nearby DNA, nullifying the benefits of the correction.
In response, a team of researchers, led by corresponding author Benjamin Kleinstiver, PhD, designed and screened dozens of base-editors with custom-made Cas9 proteins to improve targeting of the ACTA2 mutation. This new base editor protein now achieved efficacious on-target correction with minimized unwanted editing. Ultimately, a single dose of the bespoke gene-editing therapy extended survival four-fold in a mouse model of MSMDS, which was also engineered by the researchers to help investigate new treatments in animals. Mice treated with a viral vector encoding the base editor showed improvement in both brain and aortic disease and other aspects of MSMDS such as exercise intolerance were improved.
“Our lab has made progress in engineering base editors to be safer, more effective, more precise, and therefore better suited to treating genetic disease,” said Kleinstiver, an investigator in the Center for Genomic Medicine at MGH. Kleinstiver’s team also recently designed a CRISPR-Cas9 enzyme that helped save the life of an infant born with a rare metabolic disease.
“MSMDS is a disease of tremendous unmet need, and our team was excited to leverage base editing to develop a treatment for it,” said Kleinstiver.
To deliver the therapy to the vascular tissue effected in MSMDS, a team led by Casey Maguire, PhD, an investigator in the MGH Department of Neurology, designed a viral vector that specifically targets the smooth muscle that lines blood vessels. This is the first CRISPR-based therapeutic approach designed to specifically target the vasculature, which is diseased and rapidly progressing in infants with MSMDS.
The researchers have already engaged with the U.S. Food and Drug Administration, paving the way for a clinical trial. With guidance from Mass General Brigham’s Innovation team as well as the Gene and Cell Therapy Institute, the program has advanced toward IND filing and secured FDA rare disease designations – milestones that will accelerate development.
Eventually, this research may also help advance cures for other conditions involving the vasculature, like moyamoya, Marfan syndrome and Loeys-Dietz syndrome, and even diseases like atherosclerosis, a leading cause of cardiovascular disease and the most common cause of death worldwide according to the World Health Organization.
“The impact of this work extends beyond just one disease,” said Mark Lindsay, MD, PhD, a pediatric cardiologist within the Mass General Brigham Heart and Vascular Institute. “Our team has created tools that have accelerated the field of genome-editing and precision therapeutics to levels that were unthinkable just two years ago. Cures are possible, but only if we continue to support biomedical research.”
Authorship: In addition to Musolino, Kleinstiver and Lindsay, Mass General Brigham authors include Christiano R. R. Alves, Sabyasachi Das, Vijai Krishnan, Leillani L. Ha, Lauren R. Fox, Hannah E. Stutzman, Claire E. Shamber, Pazhanichamy Kalailingam, Siobhan McCarthy, Christian L. Lino Cardenas, Claire E. Fong, Takahiko Imai, Sunayana Mitra, Shuqi Yun, Rachael K. Wood, Kangsan Roh, Joseph Lawton, Nahye Kim, Rachel A. Silverstein, Joana Ferreira da Silva, Demitri de la Cruz, Rashmi Richa, Jun Xie, Heather L. Gray-Edwards, Rajeev Malhotra, David Y. Chung, Luke H. Chao, and Casey A. Maguire. Additional authors include Friederike M. C. Benning, Shengdar Q. Tsai.
Paper cited: Alves CRR et al. “Treatment of a severe vascular disease using a bespoke CRISPR–Cas9 base editor in mice” Nature Biomedical Engineering DOI: 10.1038/s41551-025-01499-1
###
About Mass General Brigham
Mass General Brigham is an integrated academic health care system, uniting great minds to solve the hardest problems in medicine for our communities and the world. Mass General Brigham connects a full continuum of care across a system of academic medical centers, community and specialty hospitals, a health insurance plan, physician networks, community health centers, home care, and long-term care services. Mass General Brigham is a nonprofit organization committed to patient care, research, teaching, and service to the community. In addition, Mass General Brigham is one of the nation’s leading biomedical research organizations with several Harvard Medical School teaching hospitals. For more information, please visit massgeneralbrigham.org.
END
Johns Hopkins researchers have discovered new materials and a new process that could advance the ever-escalating quest to make smaller, faster and affordable microchips used across modern electronics—in everything from cellphones to cars, appliances to airplanes.
The team of scientists has discovered how to create circuits that are so small they’re invisible to the naked eye using a process that is both precise and economical for manufacturing.
The findings are published today in the journal Nature Chemical Engineering.
“Companies have their roadmaps ...
-With images-
Durham University scientists have completed one of the largest quality verification programmes ever carried out on superconducting materials, helping to ensure the success of the world’s biggest fusion energy experiment ITER.
Their findings, published in Superconductor Science and Technology, shed light not only on the quality of the wires themselves but also on how to best test them, providing crucial knowledge for scientists to make fusion energy a reality.
Fusion (the process that powers the Sun) has long been described as the holy grail of clean energy. It offers the promise of a virtually limitless power source with no carbon emissions ...
The latest survey from the European Centre for Disease Prevention and Control (ECDC), the fourth of its kind, confirms that Candidozyma auris (formerly Candida auris) continues to spread quickly across European hospitals, posing a serious threat to patients and healthcare systems. Case numbers are rising, outbreaks are growing in scale, and several countries report ongoing local transmission. The findings highlight the importance of early detection and control of transmission to avoid widespread rapid dissemination.
Candidozyma auris (C. auris) is a ...
Recent research suggests that many of the Bronze Age people buried in Seddin, Germany, were not locals but came from outside the region. While archaeologists had previously uncovered artefacts from other parts of Europe around Seddin, this new study reveals that people themselves travelled and settled in Seddin.
This is the first bioarchaeological investigation on human skeletal remains from the Seddin area. While studying archaeological artefacts can reveal trade and exchange between different areas, it cannot determine whether this was accompanied by human travel. This new study sheds light on how people ...
In the Cretaceous period, Earth was plagued by widespread volcanic activity, oceanic oxygen depletion events, and mass extinctions. Fossils from that era remain and continue to give scientists clues as to what the climate may have looked like in different regions.
Now, researchers in China have examined some of them: dinosaur eggs found at the Qinglongshan site in the Yunyang Basin in central China. This is the first time that dinosaur eggs have been dated using carbonate uranium-lead (U-Pb) dating. The team published their results in Frontiers in Earth Science.
“We show that these dinosaur eggs were deposited roughly 85 million years ago, ...
Vibrations are everywhere—from the hum of machinery to the rumble of transport systems. Usually, these random motions are wasted and dissipated without producing any usable work. Recently, scientists have been fascinated by “ratchet systems” which are mechanical systems that rectify chaotic vibrations into directional motion. In biology, molecular motors achieve this feat within living cells to drive the essential processes by converting random molecular collisions into purposeful motions. However, at a large scale, these ratchet systems have always relied on built-in asymmetry, such as gears or ...
A landmark study led by the University of Sydney has found no evidence that family-based early obesity prevention programs, such as home visits from health professionals or community parent groups, improve overall body mass index (BMI) in young children.
Published in The Lancet, the study was led by Dr Kylie Hunter from the Faculty of Medicine and Health as part of the TOPCHILD collaboration with multiple scientists including those at the University Medical Center Rostock and Flinders University.
Early weight is a strong predictor of future weight ...
Tsukuba, Japan—The rapid rise of social media has enabled real-time interaction among users, accelerating and complicating the ways emotions influence human behavior. Yet the specific mechanisms through which emotions are transmitted and tied to viewer responses, particularly in settings where video and viewer comments are synchronized, remain poorly understood.
Grounded in the Emotions as Social Information (EASI) theory, which argues that emotional expressions function as vital social signals, the research team examined more than 50,000 barrage comments. ...
New research from the University of Sydney’s Charles Perkins Centre has found that genes play an active role in shaping the bacteria found in our gut, questioning the idea that gut health is influenced only by diet.
The gut microbiome is increasingly seen as vital to overall health, with Australia's gut health supplement industry valued at over $400 million in 2024.
“After decades of research linking the gut microbiome to almost every chronic disease, it may seem like we’re all ...
Research led by Liverpool School of Tropical Medicine and the Malawi-Liverpool-Wellcome Programme shows that over half of hospital patients with breathlessness had died within a year of admission (51%), as opposed to just 26% of those without the symptom.
Most of these patients had more than one condition that cause breathlessness, including pneumonia, anaemia, heart failure and TB.
The findings demonstrate the importance of integrated, patient-centred care, researchers say, to tackle the burden of high mortality ...
